donor_id,gender,primary_site,vital_status,diagnosis_id,age_at_diagnosis,cancer_type,staging_system,stage,specimen_id,specimen_type,tissue_source,sample_id,sample_type,treatment_id,treatment_type,treatment_duration,treatment_response,followup_id,followup_interval,disease_status
DO0599,Female,Breast,Alive,PD059901,52,C50.1,AJCC 8th edition,Stage IIA,SP0599,Primary tumour,Solid tissue,SA0599,Total DNA,TR0599,Chemotherapy,120,Complete response,FU0599,180,No evidence of disease
DO0600,Male,Prostate gland,Alive,PD059902,68,C61,Gleason grade group system,Grade Group 2,SP0600,Primary tumour,Solid tissue,SA0600,Total DNA,TR0600,Hormonal therapy,240,Partial response,FU0600,150,Stable disease
DO0601,Female,Ovary,Deceased,PD059903,59,C56,FIGO staging system,Stage IIIC,SP0601,Primary tumour,Solid tissue,SA0601,Total DNA,TR0601,Chemotherapy,90,Disease progression,FU0601,120,Progression NOS
DO0602,Male,Lung,Alive,PD059904,64,C34.1,AJCC 8th edition,Stage IIB,SP0602,Primary tumour,Solid tissue,SA0602,Total DNA,TR0602,Radiation therapy,60,Partial response,FU0602,90,Stable disease
DO0603,Female,Thyroid gland,Alive,PD059905,45,C73,AJCC 8th edition,Stage I,SP0603,Primary tumour,Solid tissue,SA0603,Total DNA,TR0603,Surgery,1,Complete response,FU0603,180,No evidence of disease
